Cooper Companies | COO - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Abbott USD 5.86B 675M 2026-03
Align Technology USD 736.59M 53M 2026-03
AtriCure USD 109.31M 3.97M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Bausch Health Companies USD 2B 67M 2025-12
Baxter International USD 891M 314M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
Dentsply International USD 427M 16M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 6.01B 595M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Novartis USD 10.07B 758M 2026-03
ResMed USD 890.98M 12.26M 2026-03
STAAR Surgical USD 43.74M 34.13M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Utah Medical Products USD 5.8M 450K 2024-09
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12